These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9233716)

  • 21. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
    Benghiat FS; Graca L; Braun MY; Detienne S; Moore F; Buonocore S; Flamand V; Waldmann H; Goldman M; Le Moine A
    Transplantation; 2005 Mar; 79(6):648-54. PubMed ID: 15785370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines.
    Plain KM; Fava L; Spinelli A; He XY; Chen J; Boyd R; Davidson CL; Hall BM
    Transplantation; 1997 Dec; 64(11):1559-67. PubMed ID: 9415556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    Transplantation; 1997 Dec; 64(11):1525-31. PubMed ID: 9415551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production.
    Verma ND; Boyd R; Robinson C; Plain KM; Tran GT; Hall BM
    Transplantation; 2006 Nov; 82(10):1324-33. PubMed ID: 17130782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts.
    Yan Y; van der Putten K; Bowen DG; Painter DM; Kohar J; Sharland AF; McCaughan GW; Bishop GA
    Transplantation; 2002 Apr; 73(7):1123-30. PubMed ID: 11965044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
    Barbara JA; Turvey SE; Kingsley CI; Spriewald BM; Hara M; Witzke O; Morris PJ; Wood KJ
    Transplantation; 2000 Dec; 70(11):1641-9. PubMed ID: 11152227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection.
    Singh NP; Guo L; Mhoyan A; Shirwan H
    Transplantation; 2003 Mar; 75(5):586-90. PubMed ID: 12640294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation of skin allograft survival is associated with reduced Th1 cytokine responses in the WKY-->F344 rat model.
    Nicolaidou E; Okada Y; Zuo XJ; Toyoda M; Marchevsky A; Matloff J; Jordan SC
    Transplantation; 1999 Nov; 68(9):1393-401. PubMed ID: 10573081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning.
    Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H
    Transplantation; 1997 Sep; 64(5):752-7. PubMed ID: 9311715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated rejection of Fas ligand-expressing heart grafts.
    Takeuchi T; Ueki T; Nishimatsu H; Kajiwara T; Ishida T; Jishage K; Ueda O; Suzuki H; Li B; Moriyama N; Kitamura T
    J Immunol; 1999 Jan; 162(1):518-22. PubMed ID: 9886428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.
    Heidecke CD; Hancock WW; Westerholt S; Sewczik T; Jakobs F; Zantl N; Varzaru A; Siegling A; Kurrle R; Deusch K; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(6):948-56. PubMed ID: 8623165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance.
    Krieger NR; Most D; Bromberg JS; Holm B; Huie P; Sibley RK; Dafoe DC; Alfrey EJ
    Transplantation; 1996 Nov; 62(9):1285-92. PubMed ID: 8932273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts.
    Jiang H; Yang X; Soriano RN; Fujimura T; Krishnan K; Kobayashi M
    Immunobiology; 2000 Sep; 202(3):280-92. PubMed ID: 11045663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redefining peripheral tolerance in the BALB/c to CBA mouse cardiac allograft model: vascular and cytokine analysis after transient CD4 T cell depletion.
    Mottram PL; Raisanen-Sokolowski A; Glysing-Jensen T; Stein-Oakley AN; Russell ME
    Transplantation; 1998 Dec; 66(11):1510-8. PubMed ID: 9869093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF; Rajotte RV
    Transplantation; 1995 Aug; 60(4):368-74. PubMed ID: 7652767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine mRNA expression in tolerant heart allografts after immunosuppression with cyclosporine, sirolimus or brequinar.
    Tian L; Stepkowski SM; Qu X; Wang ME; Wang M; Yu J; Kahan BD
    Transpl Immunol; 1997 Sep; 5(3):189-98. PubMed ID: 9402685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.